DexCom (DXCM) Tops Q3 EPS by 26c
Get Alerts DXCM Hot Sheet
Price: $77.94 -0.49%
EPS Growth %: +9.8%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +9.8%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.89, $0.26 better than the analyst estimate of $0.63. Revenue for the quarter came in at $650.2 versus the consensus estimate of $618.36 million.
GUIDANCE:
DexCom sees FY2021 revenue of $2.425-2.45 billion, versus the consensus of $2.4 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Wells Fargo Names Top Pick Ahead of Q3 Earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share